Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
HealthEquity appoints Tyson Murdock as deputy CFO, to succeed CFO Darcy Mott » 08:17
06/26/20
06/26
08:17
06/26/20
08:17
HQY

HealthEquity

$62.04 /

+2.03 (+3.38%)

HealthEquity announced…

HealthEquity announced that Tyson Murdock has been appointed EVP and Deputy CFO, effective July 1, 2020, and will succeed Darcy Mott as CFO April 1, 2021. Mr. Mott will continue in his current position as EVP and CFO through March 31, 2021 to ensure a smooth transition and completion of the fiscal year 2021 Form 10-K filing for the Company and will then transition into an advisory role to the CEO. Murdock joined HealthEquity in 2018 as SVP and Corporate Controller and brings 25 years of corporate finance experience to his new role as CFO.

ShowHide Related Items >><<
HQY HealthEquity
$62.04 /

+2.03 (+3.38%)

HQY HealthEquity
$62.04 /

+2.03 (+3.38%)

06/03/20 Barrington
HealthEquity earnings selloff a buying opportunity, says Barrington
06/03/20 Cantor Fitzgerald
HealthEquity price target lowered to $70 from $80 at Cantor Fitzgerald
04/14/20 Guggenheim
Guggenheim starts HealthEquity at Buy with $56 price target
04/14/20 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
HQY HealthEquity
$62.04 /

+2.03 (+3.38%)

  • 10
    Jul
HQY HealthEquity
$62.04 /

+2.03 (+3.38%)

Over a month ago
Recommendations
HealthEquity earnings selloff a buying opportunity, says Barrington » 09:51
06/03/20
06/03
09:51
06/03/20
09:51
HQY

HealthEquity

$57.83 /

-4.62 (-7.40%)

Barrington analyst…

Barrington analyst Alexander Paris recommends using today's post-earnings selloff in shares of HealthEquity as a buying opportunity. The quarter was mixed as revenue was slightly below and adjusted EBITDA was slightly above expectations, and guidance for fiscal 2021 was withdrawn given the uncertainty related to COVID-19, Paris tells investors in a research note. The pandemic has impacted HealthEquity's results more than originally thought, but the company's financial performance should improve as the economy gradually begins to reopen, says the analyst. Paris reiterates an Outperform rating on HealthEquity with a $65 price target.

ShowHide Related Items >><<
HQY HealthEquity
$57.83 /

-4.62 (-7.40%)

HQY HealthEquity
$57.83 /

-4.62 (-7.40%)

06/03/20 Cantor Fitzgerald
HealthEquity price target lowered to $70 from $80 at Cantor Fitzgerald
04/14/20 Guggenheim
Guggenheim starts HealthEquity at Buy with $56 price target
04/14/20 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
04/13/20 SVB Leerink
HealthEquity initiated with a Market Perform at SVB Leerink
HQY HealthEquity
$57.83 /

-4.62 (-7.40%)

HQY HealthEquity
$57.83 /

-4.62 (-7.40%)

Recommendations
HealthEquity price target lowered to $70 from $80 at Cantor Fitzgerald » 07:27
06/03/20
06/03
07:27
06/03/20
07:27
HQY

HealthEquity

$62.45 /

+0.24 (+0.39%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Steven Halper lowered the firm's price target on HealthEquity to $70 from $80 and keeps an Overweight rating on the shares following the company's quarterly results, saying the company began to feel the negative effects of COVID-19 in March. While the near-term outlook appears soft, Halper believes that the company should be well-positioned beyond COVID and remains confident that HealthEquity should continue to gain market share despite the uncertain environment.

ShowHide Related Items >><<
HQY HealthEquity
$62.45 /

+0.24 (+0.39%)

HQY HealthEquity
$62.45 /

+0.24 (+0.39%)

04/14/20 Guggenheim
Guggenheim starts HealthEquity at Buy with $56 price target
04/14/20 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
04/13/20 SVB Leerink
HealthEquity initiated with a Market Perform at SVB Leerink
04/08/20 Raymond James
HealthEquity price target lowered to $75 from $90 at Raymond James
HQY HealthEquity
$62.45 /

+0.24 (+0.39%)

HQY HealthEquity
$62.45 /

+0.24 (+0.39%)

On The Fly
Fly Intel: After-Hours Movers » 19:10
06/02/20
06/02
19:10
06/02/20
19:10
APPS

Digital Turbine

$6.86 /

+0.245 (+3.71%)

, CRWD

Crowdstrike

$92.17 /

-2.675 (-2.82%)

, MCHP

Microchip

$96.93 /

+1.23 (+1.29%)

, CAKE

Cheesecake Factory

$20.94 /

+0.19 (+0.92%)

, AVID

Avid Technology

$7.49 /

+0.04 (+0.54%)

, LYFT

Lyft

$31.70 /

-0.92 (-2.82%)

, HQY

HealthEquity

$62.45 /

+0.24 (+0.39%)

, AMBA

Ambarella

$61.51 /

+3.72 (+6.44%)

, ZM

Zoom Video

$208.00 /

+3.85 (+1.89%)

, MDLA

Medallia

$29.48 /

-0.35 (-1.17%)

, RGA

Reinsurance Group

$94.19 /

+2.26 (+2.46%)

, EVFM

Evofem

$4.68 /

-0.41 (-8.06%)

, GLUU

Glu Mobile

$9.95 /

-0.34 (-3.30%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
ZM Zoom Video
$208.00 /

+3.85 (+1.89%)

RGA Reinsurance Group
$94.19 /

+2.26 (+2.46%)

MDLA Medallia
$29.48 /

-0.35 (-1.17%)

MCHP Microchip
$96.93 /

+1.23 (+1.29%)

LYFT Lyft
$31.70 /

-0.92 (-2.82%)

HQY HealthEquity
$62.45 /

+0.24 (+0.39%)

GLUU Glu Mobile
$9.95 /

-0.34 (-3.30%)

EVFM Evofem
$4.68 /

-0.41 (-8.06%)

CRWD Crowdstrike
$92.17 /

-2.675 (-2.82%)

CAKE Cheesecake Factory
$20.94 /

+0.19 (+0.92%)

AVID Avid Technology
$7.49 /

+0.04 (+0.54%)

APPS Digital Turbine
$6.86 /

+0.245 (+3.71%)

AMBA Ambarella
$61.51 /

+3.72 (+6.44%)

APPS Digital Turbine
$6.86 /

+0.245 (+3.71%)

05/27/20 Canaccord
Digital Turbine a near-term and long-term winner, says Canaccord
03/05/20 B. Riley FBR
Digital Turbine price target raised to $10 from $8.75 at B. Riley FBR
03/04/20 Canaccord
Digital Turbine price target raised to $12 from $8 at Canaccord
12/17/19 National Securities
Digital Turbine reinstated with a Buy at National Securities
CRWD Crowdstrike
$92.17 /

-2.675 (-2.82%)

06/01/20 Barclays
Crowdstrike jumps after Barclays boosts target $100 ahead of results
06/01/20 DA Davidson
Crowdstrike price target raised to $105 from $60 at DA Davidson
05/28/20 RBC Capital
Crowdstrike price target raised to $90 from $73 at RBC Capital
05/20/20 SunTrust
Crowdstrike price target raised to $95 from $80 at SunTrust
MCHP Microchip
$96.93 /

+1.23 (+1.29%)

06/02/20 Mizuho
Microchip price target raised to $105 from $92 at Mizuho
05/08/20 Morgan Stanley
Microchip macro commentary 'sobering,' says Morgan Stanley
04/13/20 SunTrust
Microchip price target raised to $94 from $90 at SunTrust
04/13/20 Morgan Stanley
Morgan Stanley downgrades Texas Instruments to Underweight on gross margins risk
CAKE Cheesecake Factory
$20.94 /

+0.19 (+0.92%)

05/13/20
Fly Intel: Top five analyst downgrades
05/13/20 Stephens
Cheesecake Factory resumed Underweight from Equal Weight at Stephens
05/07/20 Loop Capital
Cheesecake Factory price target lowered to $23 from $44 at Loop Capital
04/23/20 Wells Fargo
Cheesecake Factory price target lowered to $26 from $50 at Wells Fargo
AVID Avid Technology
$7.49 /

+0.04 (+0.54%)

05/19/20 Northland
Northland starts Avid Technology at Outperform, sees snap back in demand coming
05/19/20 Northland
Avid Technology initiated with an Outperform at Northland
05/11/20 Jefferies
Avid Technology price target lowered to $6.50 from $8.50 at Jefferies
04/08/20 Jefferies
Avid Technology recurring business 'holding up,' says Jefferies
LYFT Lyft
$31.70 /

-0.92 (-2.82%)

05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/27/20 Northcoast
Ride hailing drivers believe April marked the bottom, says Northcoast
05/21/20 Loop Capital
Lyft price target lowered to $41 from $62 at Loop Capital
05/11/20
Fly Intel: Top five analyst downgrades
HQY HealthEquity
$62.45 /

+0.24 (+0.39%)

04/14/20 Guggenheim
Guggenheim starts HealthEquity at Buy with $56 price target
04/14/20 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
04/13/20 SVB Leerink
HealthEquity initiated with a Market Perform at SVB Leerink
04/08/20 Raymond James
HealthEquity price target lowered to $75 from $90 at Raymond James
AMBA Ambarella
$61.51 /

+3.72 (+6.44%)

05/29/20
Fly Intel: Top five analyst initiations
05/29/20 Baird
Ambarella initiated with a Neutral at Baird, with secular growth opps. ahead
05/28/20 Stifel
Ambarella price target raised to $62 from $60 at Stifel
05/28/20 Baird
Ambarella initiated with a Neutral at Baird
ZM Zoom Video
$208.00 /

+3.85 (+1.89%)

05/27/20 Baird
Zoom Video price target raised to $180 from $120 at Baird
05/15/20 Citi
Zoom Video initiated with a Neutral at Citi
05/04/20 Piper Sandler
Zoom Video price target raised to $144 from $110 at Piper Sandler
04/23/20 JPMorgan
Zoom Video strength related to CEO comments on user growth, says JPMorgan
MDLA Medallia
$29.48 /

-0.35 (-1.17%)

04/13/20 Needham
Needham cuts price targets across SaaS/Application Software names
01/17/20
Fly Intel: Top five analyst initiations
01/16/20 Baird
Medallia initiated with an Outperform at Baird
12/06/19 Oppenheimer
Oppenheimer says would add to Medallia positions on any weakness
RGA Reinsurance Group
$94.19 /

+2.26 (+2.46%)

05/29/20 Piper Sandler
Reinsurance Group initiated with a Neutral at Piper Sandler
04/27/20 Credit Suisse
Reinsurance Group price target lowered to $110 from $144 at Credit Suisse
04/07/20 JPMorgan
Reinsurance Group upgraded to Overweight on defensive position at JPMorgan
04/07/20 JPMorgan
Reinsurance Group upgraded to Overweight from Neutral at JPMorgan
EVFM Evofem
$4.68 /

-0.41 (-8.06%)

04/16/20 Roth Capital
Roth believes Evofem 'underappreciated' ahead of Phexxi PDUFA date
12/18/19 Roth Capital
Evofem's Amphora getting closer to FDA approval, says Roth Capital
12/11/19 H.C. Wainwright
Evofem price target raised to $11 from $9 at H.C. Wainwright
10/16/19 Cantor Fitzgerald
Evofem assumed with an Overweight at Cantor Fitzgerald
GLUU Glu Mobile
$9.95 /

-0.34 (-3.30%)

05/29/20 Benchmark
Benchmark reiterates Buy rating on Glu Mobile after guidance hike
05/29/20 Piper Sandler
Glu Mobile outlook still conservative despite uptick, says Piper Sandler
05/11/20 Morgan Stanley
Morgan Stanley downgrades Glu Mobile after stock nearly doubled
ZM Zoom Video
$208.00 /

+3.85 (+1.89%)

RGA Reinsurance Group
$94.19 /

+2.26 (+2.46%)

MDLA Medallia
$29.48 /

-0.35 (-1.17%)

MCHP Microchip
$96.93 /

+1.23 (+1.29%)

LYFT Lyft
$31.70 /

-0.92 (-2.82%)

HQY HealthEquity
$62.45 /

+0.24 (+0.39%)

GLUU Glu Mobile
$9.95 /

-0.34 (-3.30%)

EVFM Evofem
$4.68 /

-0.41 (-8.06%)

CRWD Crowdstrike
$92.17 /

-2.675 (-2.82%)

CAKE Cheesecake Factory
$20.94 /

+0.19 (+0.92%)

AVID Avid Technology
$7.49 /

+0.04 (+0.54%)

APPS Digital Turbine
$6.86 /

+0.245 (+3.71%)

AMBA Ambarella
$61.51 /

+3.72 (+6.44%)

  • 04
    Jun
  • 02
    Jun
  • 03
    Jun
ZM Zoom Video
$208.00 /

+3.85 (+1.89%)

MDLA Medallia
$29.48 /

-0.35 (-1.17%)

LYFT Lyft
$31.70 /

-0.92 (-2.82%)

CRWD Crowdstrike
$92.17 /

-2.675 (-2.82%)

CAKE Cheesecake Factory
$20.94 /

+0.19 (+0.92%)

ZM Zoom Video
$208.00 /

+3.85 (+1.89%)

MCHP Microchip
$96.93 /

+1.23 (+1.29%)

LYFT Lyft
$31.70 /

-0.92 (-2.82%)

HQY HealthEquity
$62.45 /

+0.24 (+0.39%)

GLUU Glu Mobile
$9.95 /

-0.34 (-3.30%)

CRWD Crowdstrike
$92.17 /

-2.675 (-2.82%)

CAKE Cheesecake Factory
$20.94 /

+0.19 (+0.92%)

AVID Avid Technology
$7.49 /

+0.04 (+0.54%)

ZM Zoom Video
$208.00 /

+3.85 (+1.89%)

MDLA Medallia
$29.48 /

-0.35 (-1.17%)

MCHP Microchip
$96.93 /

+1.23 (+1.29%)

LYFT Lyft
$31.70 /

-0.92 (-2.82%)

GLUU Glu Mobile
$9.95 /

-0.34 (-3.30%)

CRWD Crowdstrike
$92.17 /

-2.675 (-2.82%)

CAKE Cheesecake Factory
$20.94 /

+0.19 (+0.92%)

APPS Digital Turbine
$6.86 /

+0.245 (+3.71%)

AMBA Ambarella
$61.51 /

+3.72 (+6.44%)

Earnings
HealthEquity withdraws FY21 guidance amid COVID-19 pandemic » 16:08
06/02/20
06/02
16:08
06/02/20
16:08
HQY

HealthEquity

$62.79 /

+0.58 (+0.93%)

Said Kessler, "We…

Said Kessler, "We believe the COVID-19 pandemic's negative effect on our operating performance will fade as businesses gradually reopen, while the unprecedented economic fallout drives HSA growth and accelerates long-term trends favoring established market leaders like HealthEquity."

ShowHide Related Items >><<
HQY HealthEquity
$62.79 /

+0.58 (+0.93%)

HQY HealthEquity
$62.79 /

+0.58 (+0.93%)

04/14/20 Guggenheim
Guggenheim starts HealthEquity at Buy with $56 price target
04/14/20 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
04/13/20 SVB Leerink
HealthEquity initiated with a Market Perform at SVB Leerink
04/08/20 Raymond James
HealthEquity price target lowered to $75 from $90 at Raymond James
HQY HealthEquity
$62.79 /

+0.58 (+0.93%)

HQY HealthEquity
$62.79 /

+0.58 (+0.93%)

Earnings
HealthEquity sees Q2 EPS 23c-30c, consensus 45c » 16:08
06/02/20
06/02
16:08
06/02/20
16:08
HQY

HealthEquity

$62.70 /

+0.49 (+0.79%)

Sees Q2 revenue…

Sees Q2 revenue $168M-$173M, consensus $191.45M

ShowHide Related Items >><<
HQY HealthEquity
$62.70 /

+0.49 (+0.79%)

HQY HealthEquity
$62.70 /

+0.49 (+0.79%)

04/14/20 Guggenheim
Guggenheim starts HealthEquity at Buy with $56 price target
04/14/20 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
04/13/20 SVB Leerink
HealthEquity initiated with a Market Perform at SVB Leerink
04/08/20 Raymond James
HealthEquity price target lowered to $75 from $90 at Raymond James
HQY HealthEquity
$62.70 /

+0.49 (+0.79%)

HQY HealthEquity
$62.70 /

+0.49 (+0.79%)

Earnings
HealthEquity reports Q1 EPS 43c, consensus 44c » 16:04
06/02/20
06/02
16:04
06/02/20
16:04
HQY

HealthEquity

$62.40 /

+0.19 (+0.31%)

Reports Q1 revenue…

Reports Q1 revenue $190.01M, consensus $193.32M."The team's remarkable response to the COVID-19 pandemic has strengthened HealthEquity's culture and accelerated promised synergies," said Jon Kessler, president and CEO. "During a tumultuous quarter, 17% year-over-year increase in new HSA openings and 33% Adjusted EBITDA margin show just how deeply growth and profitability are embedded in our model."

ShowHide Related Items >><<
HQY HealthEquity
$62.40 /

+0.19 (+0.31%)

HQY HealthEquity
$62.40 /

+0.19 (+0.31%)

04/14/20 Guggenheim
Guggenheim starts HealthEquity at Buy with $56 price target
04/14/20 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
04/13/20 SVB Leerink
HealthEquity initiated with a Market Perform at SVB Leerink
04/08/20 Raymond James
HealthEquity price target lowered to $75 from $90 at Raymond James
HQY HealthEquity
$62.40 /

+0.19 (+0.31%)

HQY HealthEquity
$62.40 /

+0.19 (+0.31%)

Earnings
Notable companies reporting after market close » 14:19
06/02/20
06/02
14:19
06/02/20
14:19
ZM

Zoom Video

$209.03 /

+4.88 (+2.39%)

, CRWD

Crowdstrike

$92.85 /

-1.99 (-2.10%)

, HQY

HealthEquity

$62.00 /

-0.21 (-0.34%)

, MDLA

Medallia

$29.76 /

-0.07 (-0.23%)

, AMBA

Ambarella

$59.61 /

+1.82 (+3.15%)

Notable companies…

Notable companies reporting after the market close, with earnings consensus, include Zoom Video (ZM), consensus 9c... CrowdStrike (CRWD), consensus (6c)... HealthEquity (HQY), consensus 44c... Medallia (MDLA), consensus (2c)... Ambarella (AMBA), consensus (1c).

ShowHide Related Items >><<
ZM Zoom Video
$209.03 /

+4.88 (+2.39%)

MDLA Medallia
$29.76 /

-0.07 (-0.23%)

HQY HealthEquity
$62.00 /

-0.21 (-0.34%)

CRWD Crowdstrike
$92.85 /

-1.99 (-2.10%)

AMBA Ambarella
$59.61 /

+1.82 (+3.15%)

ZM Zoom Video
$209.03 /

+4.88 (+2.39%)

05/27/20 Baird
Zoom Video price target raised to $180 from $120 at Baird
05/15/20 Citi
Zoom Video initiated with a Neutral at Citi
05/04/20 Piper Sandler
Zoom Video price target raised to $144 from $110 at Piper Sandler
04/23/20 JPMorgan
Zoom Video strength related to CEO comments on user growth, says JPMorgan
CRWD Crowdstrike
$92.85 /

-1.99 (-2.10%)

06/01/20 Barclays
Crowdstrike jumps after Barclays boosts target $100 ahead of results
06/01/20 DA Davidson
Crowdstrike price target raised to $105 from $60 at DA Davidson
05/28/20 RBC Capital
Crowdstrike price target raised to $90 from $73 at RBC Capital
05/20/20 SunTrust
Crowdstrike price target raised to $95 from $80 at SunTrust
HQY HealthEquity
$62.00 /

-0.21 (-0.34%)

04/14/20 Guggenheim
Guggenheim starts HealthEquity at Buy with $56 price target
04/14/20 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
04/13/20 SVB Leerink
HealthEquity initiated with a Market Perform at SVB Leerink
04/08/20 Raymond James
HealthEquity price target lowered to $75 from $90 at Raymond James
MDLA Medallia
$29.76 /

-0.07 (-0.23%)

04/13/20 Needham
Needham cuts price targets across SaaS/Application Software names
01/17/20
Fly Intel: Top five analyst initiations
01/16/20 Baird
Medallia initiated with an Outperform at Baird
12/06/19 Oppenheimer
Oppenheimer says would add to Medallia positions on any weakness
AMBA Ambarella
$59.61 /

+1.82 (+3.15%)

05/29/20
Fly Intel: Top five analyst initiations
05/29/20 Baird
Ambarella initiated with a Neutral at Baird, with secular growth opps. ahead
05/28/20 Stifel
Ambarella price target raised to $62 from $60 at Stifel
05/28/20 Baird
Ambarella initiated with a Neutral at Baird
ZM Zoom Video
$209.03 /

+4.88 (+2.39%)

MDLA Medallia
$29.76 /

-0.07 (-0.23%)

HQY HealthEquity
$62.00 /

-0.21 (-0.34%)

CRWD Crowdstrike
$92.85 /

-1.99 (-2.10%)

AMBA Ambarella
$59.61 /

+1.82 (+3.15%)

ZM Zoom Video
$209.03 /

+4.88 (+2.39%)

MDLA Medallia
$29.76 /

-0.07 (-0.23%)

CRWD Crowdstrike
$92.85 /

-1.99 (-2.10%)

ZM Zoom Video
$209.03 /

+4.88 (+2.39%)

HQY HealthEquity
$62.00 /

-0.21 (-0.34%)

CRWD Crowdstrike
$92.85 /

-1.99 (-2.10%)

ZM Zoom Video
$209.03 /

+4.88 (+2.39%)

MDLA Medallia
$29.76 /

-0.07 (-0.23%)

CRWD Crowdstrike
$92.85 /

-1.99 (-2.10%)

AMBA Ambarella
$59.61 /

+1.82 (+3.15%)

Initiation
Guggenheim starts HealthEquity at Buy with $56 price target » 09:04
04/14/20
04/14
09:04
04/14/20
09:04
HQY

HealthEquity

$47.10 /

-1.78 (-3.64%)

As previously reported,…

As previously reported, Guggenheim analyst Vikram Kesavabhotia initiated coverage of HealthEquity with a Buy rating and $56 price target. While he appreciates the significant concerns around COVID-19 and the interest rate environment, Kesavabhotia sees HealthEquity being well positioned to capture continued HSA industry growth with a more comprehensive go-to-market strategy following its WageWorks deal. He sees an attractive risk/reward following the company's revised F21 guidance and pullback in the shares, along with a variety of potential growth drivers for upside.

ShowHide Related Items >><<
HQY HealthEquity
$47.10 /

-1.78 (-3.64%)

04/14/20 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
04/13/20 SVB Leerink
HealthEquity initiated with a Market Perform at SVB Leerink
04/08/20 Raymond James
HealthEquity price target lowered to $75 from $90 at Raymond James
03/27/20 Raymond James
HealthEquity price target lowered to $90 from $110 at Raymond James
Initiation
HealthEquity initiated with a Buy at Guggenheim » 06:51
04/14/20
04/14
06:51
04/14/20
06:51
HQY

HealthEquity

$47.10 /

-1.78 (-3.64%)

Guggenheim analyst Vikram…

Guggenheim analyst Vikram Kesavabhotia initiated coverage of HealthEquity with a Buy rating and $56 price target.

ShowHide Related Items >><<
HQY HealthEquity
$47.10 /

-1.78 (-3.64%)

04/13/20 SVB Leerink
HealthEquity initiated with a Market Perform at SVB Leerink
04/08/20 Raymond James
HealthEquity price target lowered to $75 from $90 at Raymond James
03/27/20 Raymond James
HealthEquity price target lowered to $90 from $110 at Raymond James
03/26/20 SunTrust
HealthEquity price target raised to $68 from $55 at SunTrust

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.